Abstract:Introduction: As of June 7, 2021, the outbreak of Coronavirus Disease 2019 (COVID-19) has spread to more than 200 countries. The global number of reported cases is more than 172.9 million, with more than 3.7 million deaths, and the number of infected individuals is still growing rapidly. Consequently, events and activities around the world were canceled or postponed, and the preparation for sporting events were greatly challenged. Under such circumstances, about 11,000 athletes from ~206 countries are arriving in Tokyo for the 32nd Summer Olympic Games. Therefore, it is urgently necessary to assess the occurrence and spread risk of COVID-19 for the Games.Objectives: To explore effective prevention and control measures for COVID-19 in large international events through simulations of different interventions according to risk assessment.Methods: We used a random model to calculate the number of initial infected patients and used Poisson distribution to determine the number of initial infected patients based on the number of countries involved. Furthermore, to simulate the COVID-19 transmission, the susceptible-exposed-symptomatic-asymptomatic-recovered-hospitalized (SEIARH) model was established based on the susceptible-exposed-infectious-recovered (SEIR) mathematical model of epidemic diseases. According to risk assessment indicators produced by different scenarios of the simulated interventions, the risk of COVID-19 transmission in Tokyo Olympic Games was assessed.Results: The current COVID-19 prevention measures proposed by the Japan Olympic Committee need to be enhanced. And large-scale vaccination will effectively control the spread of COVID-19. When the protective efficacy of vaccines is 78.1% or 89.8%, and if the vaccination rate of athletes reaches 80%, an epidemic prevention barrier can be established.

Will the Olympic flame spark dengue outbreaks during the Paris 2024 summer Olympic and Paralympic games?

Dengue virus and the 2024 Paris Olympics

Paris 2024 Olympic Games: A risk enhancer for autochthonous arboviral diseases epidemics?

From the Rio 2016 Olympics to the Paris 2024 Olympics: Is there a risk of Dengue disease?

Environmental challenges facing athletes, stakeholders and spectators at Paris 2024 Olympic and Paralympic Games: an evidence-based review of mitigation strategies and recommendations

Climate and health challenges for Paris 2024 Olympics and Paralympics

Ensembles of climate simulations to anticipate worst case heatwaves during the Paris 2024 Olympics

Autochthonous dengue in mainland France, 2022: geographical extension and incidence increase

Paris air quality monitoring for the 2024 Olympics and Paralympics: focus on air pollutants and pollen

Aedes albopictus is a competent vector of five arboviruses affecting human health, greater Paris, France, 2023

Pathogen prioritisation for wastewater surveillance ahead of the Paris 2024 Olympic and Paralympic Games, France

[Health care organization for 2024 Olympics and Paralympics Games]

Infectious risks associated with outdoor sports activities

The Dengue risk transmission during the FIFA 2014 World Cup

Who still wants the Olympic Flame? Analysing the implementation of the Olympic Torch Relay of Paris 2024

Molecular epidemiology identifies the expansion of the DENV2 epidemic lineage from the French Caribbean Islands to French Guiana and mainland France, 2023 to 2024

Underdiagnosis of arbovirus infections in returned travelers in an area with growing circulation of Aedes albopictus in North-Eastern France

Peri-domestic entomological surveillance using private traps allows detection of dengue virus in Aedes albopictus during an autochthonous transmission event in mainland France, late summer 2023

COVID-19 Risk Assessment for the Tokyo Olympic Games

Heat-related risk at Paris 2024: a proposal for classification and review of International Federations policies

Sixty seconds on . . . Zika and the Olympics